Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-103093
Filing Date
2025-10-28
Accepted
2025-10-28 14:51:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2529544-1_424b5.htm 424B5 506597
2 GRAPHIC lg_annovis-4c.jpg GRAPHIC 17598
  Complete submission text file 0001104659-25-103093.txt   532068
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-276814 | Film No.: 251423841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)